Sonoma Pharmaceuticals Inc SNOA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:57 PM EST
7.93quote price arrow down-0.22 (-2.70%)
Volume
18,283
52 week range
3.55 - 19.60

...

Loading . . .

KEY STATS

  • Open8.25
  • Day High8.53
  • Day Low7.90
  • Prev Close8.15
  • 52 Week High19.60
  • 52 Week High Date05/29/20
  • 52 Week Low3.55
  • 52 Week Low Date03/18/20
  • Market Cap16.49M
  • Shares Out2.08M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • 1 Year % Change44.45

RATIOS/PROFITABILITY

  • EPS (TTM)-1.37
  • P/E (TTM)-5.79
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-2.835M
  • ROE (MRQ)-21.74%
  • Revenue (MRQ)21.05M
  • Gross Margin (MRQ)40.54%
  • Net Margin (MRQ)-12.15%
  • Debt To Equity (MRQ)10.64%

EVENTS

  • Earnings Date06/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Sonoma Pharmaceuticals Inc News

There is no recent news for this security.

Latest SNOA News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets solutions for management of dermatological conditions and advanced tissue care. The Company's product portfolio consists of dermatology, animal health, and advanced tissue care products based upon its Microcyn technology. Its Microcyn technology family of products consists of liquids and gels, which contain small molecule oxychlorine compounds. Its products serve patients across the...
Amy Trombly J.D.
Chief Executive Officer
Bruce Thornton
Chief Operating Officer
Jerry Dvonch
Chief Financial Officer
Address
645 Molly Lane, Suite 150
Woodstock, GA
30189
United States